CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.

Murakami S, Kawanaka M, Imajo K, Shiota S, Miyake N, Sue M, Adachi T, Takeuchi Y, Onishi H, Takaki A, Urata N, Kawamoto H, Otsuka M

Open source

DOI: 10.1038/s41598-026-58113-w
Published: 2026 Jun 18
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-58113-w,
  title = {CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.},
  author = {Murakami S and Kawanaka M and Imajo K and Shiota S and Miyake N and Sue M and Adachi T and Takeuchi Y and Onishi H and Takaki A and Urata N and Kawamoto H and Otsuka M},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-58113-w},
  url = {https://doi.org/10.1038/s41598-026-58113-w}
}

RIS

TY  - JOUR
TI  - CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.
AU  - Murakami S
AU  - Kawanaka M
AU  - Imajo K
AU  - Shiota S
AU  - Miyake N
AU  - Sue M
AU  - Adachi T
AU  - Takeuchi Y
AU  - Onishi H
AU  - Takaki A
AU  - Urata N
AU  - Kawamoto H
AU  - Otsuka M
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-58113-w
UR  - https://doi.org/10.1038/s41598-026-58113-w
ER  -

APA

S, M., M, K., K, I., S, S., N, M., M, S., T, A., Y, T., H, O., A, T., N, U., H, K., & M, O. (2026). CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.. Scientific reports. https://doi.org/10.1038/s41598-026-58113-w

Source records

pubmed · retrieved 2026-09-26T17:15:24.144Z
europe-pmc · retrieved 2026-09-26T17:15:24.166Z
doaj · retrieved 2026-09-26T17:15:24.160Z